vTv Therapeutics Inc. Reports Q3 2026 Financial Results

What Happened

• vTv Therapeutics Inc. filed a Form 8‑K on August 6, 2026 to announce its financial results for the fiscal period ended June 30, 2026.
• The company issued a press release reporting those results; the release is attached to the 8‑K as Exhibit 99.1 and was signed by Paul J. Sekhri, President and Chief Executive Officer.
• The filing notes the press release is furnished (not “filed”) and therefore is not subject to Section 18 liability or automatically incorporated by reference into future registration statements.

Key Details

• Filing date: August 6, 2026.
• Reporting period: fiscal quarter ended June 30, 2026.
• Press release announcing quarterly results attached as Exhibit 99.1 to the Form 8‑K.
• Signed by Paul J. Sekhri, President and CEO.

Why It Matters

• This 8‑K signals that vTv has released its quarterly earnings/financial results; investors should review the attached press release for revenue, profit/loss, cash position, and any management commentary or guidance changes.
• Because the release is furnished (not filed), it’s disclosed to the market but has limited SEC liability and may not be automatically incorporated into other SEC filings.
• Retail investors should read the press release and subsequent SEC filings (e.g., 10‑Q when available) to get full financial detail and context before making investment decisions.